Chiral ligands for asymmetric catalysis

Details Chiral ligands for asymmetric catalysis Chiral ligands for asymmetric catalysis

1999-11-04

2001-01-09

Vollano, Jean F (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heavy metal containing

C502S162000, C544S106000, C562S450000, C560S179000, C556S022000

Reexamination Certificate

active

06172249

ABSTRACT:

FIELD OF THE INVENTION
This invention relates to phosphine ligands and metal complexes thereof, and to the use of the complexes as catalysts for asymmetric hydrogenation processes.
BACKGROUND TO THE INVENTION
The list of available chiral ligands for asymmetric catalytic transformations continues to grow at a rapid pace, and yet many desirable reactions remain impractical due to the limitations of currently available catalyst systems. In particular, achieving both high rates and high enantio selectivities in catalysis remains a serious challenge that continues to present the principal obstacle to the development of cost-effective asymmetric catalytic processes.
Burk, in Handbook of Chiral Chemicals, ed. Ager, Marcel Dekker, Inc., New York (1999), Chapter 18: 339-59, and references cited therein, reports that ligands composed of 2,5-disubstituted phospholane groups may bestow significant advantages in terms of enantioselectivities in asymmetric catalytic hydrogenation reactions. Unfortunately, catalysts that rendered the highest selectivities (e.g. DuPHOS-Rh and BPE-Rh) often displayed low catalytic rates in the hydrogenation of certain functional groups (e.g. ketones, hindered alkenes, etc.). Burk and Gross, Tet. Lett. 35:9363 (1994), report that reaction rates could be accelerated by the introduction of more flexible ligand backbones (e.g. 1,3-propano and 1,1′-ferrocenyl bridges), but enantioslectivities fell.
WO-A-98/02445 describes chiral phosphetane ligands as defined by general formula 1, or the opposite enantiomer thereof, wherein R groups are each independently H, alkyl, cycloalkyl, aryl or alkaryl, provided that R
1
and R
2
are both not H, and X is any group capable of forming a stable bond to phosphorus. In particular, WO-A-98/02445 highlights the synthetic utility of rhodium complexes of monophosphetanes of formula 2, wherein R
1
═R
2
, in comparison with five-membered ring analogues of formula 3
WO-A-99/02444 (published after the priority dates claimed in this Application) describes an improved process for the preparation of cyclic phosphines. This involves the addition of strong base to a preformed mixture or reaction product of a primary phosphine and an alkylating agent.
SUMMARY OF THE INVENTION
Novel ligands according to the present invention are bis(dialkyiphosphetano)ferrocenes of formula 4
wherein R is linear or branched alkyl (including the opposite enantiomers thereof). Unexpectedly, it has been found that these bis(dialkylphosphetano)ferrocenes have especial utility as components of catalysts for asymmetric synthesis. In particular, their transition metal complexes give superior performance in the asymmetric hydrogenation of certain prochiral substrates, in terms of improved enantioselectivity and catalytic activity, when compared with equivalent complexes of alternative known chiral pbosphine ligands.
DESCRIPTION OF THE INVENTION
Preferred ligands of the present invention arc those where R is linear alkyl, e.g. linear C
1-4
alkyl, more preferably methyl or ethyl and rhodium(I) complexes thereof. It will be understood by those skilled in the art that the term “alkyl” does not necessarily comprise C and H only, provided that any substituents have no effect on the function of the ligands.
This invention involves asymmetric hydrogenation which is applicable to a variety of substrates, especially those that might otherwise require forcing conditions, or where other ligands give no or little conversion. Examples of such substrates are those with C═C bonds, e.g. tetrasubstituted alkenes and also itaconic acid derivatives such as esters (whether or not &bgr;-substituted or &bgr;,&bgr;′-disubstituted), those with C═O bonds, e.g. ketones and &agr;-ketoacids, and those with C═N bonds, e.g. oximes and imines that can be converted to chiral hydroxylamines and chiral amines, respectively. As is evident from the Examples below, a particular class of substrates that can be hydrogenated according to this invention, has the partial formula C═C(C═O)—C—C═O, especially C═C(COOH)—C—C═O.
The hydrogenation reaction may be conducted under conditions that are known to, or can be determined by, those skilled in the art. Examples are given below.
The novel 1,1′-bis(phosphetano)ferrocenes may be prepared by known procedures, or as generally disclosed in WO-A-99/02444. Suitable reactants are of the formulae
which may be reacted in the presence of an alkylithium, in THF. The cyclic sulfates may be prepared starting from enantiomerically pure 1,3-diols. These diols may be prepared through asymmetric hydrogenation of 1,3-diketones using well-documented procedures involving catalysts such as Ru-BINAP catalysts; see Noyori et al, JACS 110:629 (1988). Subsequently, the diols may be converted to 1,3-diol cyclic sulfates through treatment with thionyl chloride followed by Ru-catalyzed oxidation with sodium periodate. Reaction between the cyclic sulfates cyclic sulfates and 1,1′-bis(phosphino)ferrocene in the presence of a strong base such as s-BuLi gives the desired ligands (4). For utilisazion as catalysts in asymmetric hydrogenation, rhodium complexes of (4) are of the form [Rh(4)(COD)]BF
4
, which are prepared by sequential reaction of Rh(COD)acac with COD (1,5-cyclooctadiene), HBF
4
—OEt
2
and the ligand (4).
The invention is further illustrated by the following Examples. Examples 1-5 describe the preparation of ligands of formula (4). Examples 6-10 describe the preparation of the corresponding rhodium complexes. Examples 11-15 describe the use of the complexes as catalysts for asymmetric hydrogenation process and include comparisons with rhodium complexes of other chiral ligands. Hydrogenation conditions for these examples are shown in individual equations (80 psi=550 kPa). In all cases, rhodium complexes are of the form [Rh(Ligand)(COD)]BF
4
wherein Ligand is a chiral diphosphine ligand. Ligands are denoted by acronyms, as follows:
Fc-4-Me, Fc-4-Et, Fc-4-Pr, Fc-4-i-Pr and Fc-4-t-Bu are ligands (4) of the present invention; and Fc-5-Me and Fc-5-Et are analogues of (4) containing five-membered phospholane rings, as described by Burk and Gross, supra.
For definitions of BINAP, bppm DIP AMP and DPHOS, see Noyori, in Catalytic Asymmetric Synthesis, ed. Ojima, VCH Inc., New York (1993).
For a definition of PHANEPHOS, see Pye ei al., JACS 119:6207 (1997).
General Procedure 1 Ligands
A 500 ml three-necked flask was equipped with magnetic stirrer bar, a dropping funnel on the middle neck, a reflux condenser with bubbler and a septum on the third neck. In this flask was made up under nitrogen a solution of 8.4 mmol of the cyclic sulphate in 250 mL of THF. The flask was immersed in an ice bath, and the solvent was degassed by bubbling nitrogen through it using a capillary bleed. In the dropping funnel was prepared a solution of 35.2 mmol of s-BuLi in 50 mL of pentane under nitrogen. After 45 minutes of solvent degassing, 2.0 g (8 mmol) of 1,1′-bis(phosphino)ferrocene was added via a syringe to the THF-solution. Then vigorous stirring was started, and the diluted solution of the s-BuLi was added dropwise into the vortex. At the end of the addition, the reaction was quenched by the addition of ca 3 mL of methanol, and the solvent was removed in vacuum. To the residue was added water (ca. 150 mL), and then the ligand was extracted into pentane (2×100 mL). Evaporation of the solvent from the dried combined organic layers provided the crude product which was purified further by recrystalisation from methanol.


REFERENCES:
patent: 5399771 (1995-03-01), Cai et al.
patent: 5563309 (1996-10-01), Togni et al.
patent: 5565594 (1996-10-01), Spindler et al.
patent: 5817850 (1998-10-01), Pastor et al.
patent: 5856540 (1999-01-01), Jendralla
patent: 5912375 (1999-06-01), Spindler et al.
patent: 5936109 (1999-08-01), Berens
patent: 2262284 (1993-06-01), None
patent: 9301199 (1993-01-01), None
patent: 9802445 (1998-01-01), None
Stephen R. Wilson, Alex Pasternak (1990) “Preparation of a New Class of C2

Affiliated with

Also associated with

Rating

Chiral ligands for asymmetric catalysis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chiral ligands for asymmetric catalysis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chiral ligands for asymmetric catalysis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2525068